Mandate

Vinge advises Artimplant in connection with new share issue

August 03, 2010

The board of directors of Artimplant AB (publ) has resolved to recommend that an extraordinary shareholders’ meeting adopt a resolution in respect of a rights issue to the existing members in order to provide the company with SEK 40,000,000 after issue costs.

Artimplant is listed on NASDAQ OMX Stockholm.

Vinge’s team primarily consisted of responsible partner Anders Strid and associates Anna Björk Larson and Emma Kero Ljungberg.

Related

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026

Vinge advises Consolid Equity in connection with the establishment of Petra Group

Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026